Event News

SEED Competition Business Plan Submission Deadline:
Feb. 14th, 2010
Submit Now!

Latest Headlines

ChinaBio® Today

Free Newsletter

ChinaBio® Today
Email address:

Now on Twitter!

 
Twitter ID: ChinaBio

ChinaBio® Events

SEED Finalists Coaching Day

Shanghai, China

March 2, 2010

SEED Final Competition and Award Ceremony

Shanghai, China

April 23, 2010

ChinaBio® Partnering Forum 2010 - Suzhou

Suzhou, China

June 23-24, 2010
More details...

Partner Events

BIO-Europe Spring® 2010

Barcelona, Spain

March 8–10, 2010

World CRO Summit 2010

Shanghai, China

March 11-12, 2010
More details...

Partners

Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners

ChinaBio® LLC

 

Shanghai Global Financial CenterSince our founding in January, 2007, ChinaBio® LLC has rapidly launched a number of successful initiatives connecting China biotech with the world.  With offices in Shanghai, San Diego and Silicon Valley, our team of industry experts is truly Helping China biotech become global biotech™. 

Conferences
ChinaBio® has established a reputation for organizing the premier life science investment and partnering conferences in China.  Our ChinaBio® Investor Forums have helped China companies raise over $140M in funding.  Our new ChinaBio® Partnering Forum, the first partnering event held in China, attracted over 500 attendees.  And now we're expanding into the US with ChinaBio® Day in San Francisco. 
Consulting
ChinaBio® provides a wide range of services to help entrepreneurs, investors, big pharma and other MNCs achieve success in China. If you are a U.S. life science company looking to establish relationships or operations in China, or a China company seeking investors or partners in the U.S., ChinaBio® has the expertise and talent to help.
  • China strategy development
  • Market/competitive intelligence
  • Technology and partner searches
  • Partner selection and management
  • Virtual drug development
  • Funding strategy and assistance
ChinaBio® Accelerator
China made quick, simple and safe
 
ChinaBio® helps U.S. life science companies leverage China’s resources: technology, capital and services. We have helped companies establish operations, secure partnerships, license technologies, and raise millions of dollars in China. We also maintain facilities in two of the leading life science parks - Zhangjiang Hi-Tech Park (Shanghai) and BioBay (Suzhou) - or we can help our clients establish their own facilities in most major life science parks in China.
 
Our end-to-end services include:
  • Establish JV or subsidiary company in China
  • Interface with government agencies
  • Raise funding from government & VC
  • Setup facility/laboratory
  • Recruiting/staffing assistance
  • Secure and manage partnerships
  • Regulatory approval assistance (SFDA/FDA)
  • Ongoing management, oversight and/or guidance
  • Business development and strategic alliances
Industry Research & Databases
ChinaBio® has assembled a comprehensive picture of China's life science landscape. Whether you're seeking the next technology, a research partner, or a company to manufacture your latest drug or device, ChinaBio can quickly assess the market identify the partner or technology you're seeking, leveraging our proprietary information.
 
We track a wide range of industry data:  
  • Government research funding
  • Novel technology / drug developmenta
  • Clinical trial activity
  • VC investments and IPOs
  • M&A and partnering deals
And have developed numerous proprietary databases:
  • 7500  life science companies
  • 2500 professors / researchers
  • 2500 novel drugs / technologies 
  • 500 institutes / universities
  • 250 recipients of over $1B in grants
  • 200 life science incubators
ChinaBio® Today
ChinaBio® Today is an email and online newsletter focusing exclusively on the rapidly evolving biotech and life science industries in China. From our offices in Shanghai and California, we provide daily news, commentary and analysis on public and private China life science companies and industry events, as well as global issues affecting the China life science market to over 17,000 readers.
 
 

For more information about any of our services, please contact us.